Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-06-25 | Effective May 5, 2020, the Company and Dr. Maida entered into an independent consulting agreement, under which Dr. Maida will assist the Company in providing medical expertise and advice from time to time in the design, conduct and oversight of the Company’s existing and future clinical trials. |
Data sourced from SEC filings. Last updated: 2025-10-12